Biomarkers and the Complex Diagnosis of Alzheimer's Disease: Amyloid-PET Imaging in Clinical Practice

Available until November 28, 2014

Target Audience:

This activity is designed to meet the educational needs of neurologists, imaging technologists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer's Disease.

Program Overview:

This case-based enduring activity will cover the diagnosis, treatment and management of patients with Alzheimer's disease (AD).

This CME activity is sponsored by Med Learning Group.

This activity is supported by an educational grant from Eli Lilly and Company

This program is being developed in association with the Florida Medical Association

If you have any questions regarding this activity, send an email to info@medlearninggroup.com.

Amyloid-PET Imaging in Clinical Practice — 1.0 AMA PRA Category 1™ Credit Hours